First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer

Clinical trial NCT07355205 · RECRUITING

Trial details

NCT number: NCT07355205
Sponsor: Washington University School of Medicine
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer Recurrent

Start date: 2026-07-07
Primary completion: 2032-07-31
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.